Differentiation state of skin fibroblast cultures versus risk of subcutaneous fibrosis after radiotherapy

Radiotherapy and Oncology

Volumn 47, Issue 3, 1998, Pages 263-269

  Herskind, Carsten ^a,b,c   Bentzen, Søren M ^b   Overgaard, Jens ^b   Overgaard, Marie ^b   Bamberg, Michael ^a   Rodemann, H Peter ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c Sect Radiobiol/Molec Environ R   (Germany)

Author keywords

Differentiation; Fibroblasts; Fibrosis; Normal tissue response; Predictive test; Radiotherapy

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CELL DIFFERENTIATION; CLINICAL ARTICLE; CLONOGENIC ASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIVITY; SKIN FIBROBLAST; SKIN FIBROSIS; STEM CELL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; FIBROBLASTS; FIBROSIS; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PROGNOSIS; RADIATION TOLERANCE; RADIODERMATITIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN;

EID: 0031745324     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(98)00018-8     Document Type: Article

References (45)

1. Anscher, M.S., Kong, F.M., Marks, L.B., Bentel, G.C. and Jirtle, R.L. Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 37: 253-258, 1997.
2. Barcellos-Hoff, M.H. Radiation-induced transforming growth factor and subsequent extracellular matrix reorganization in murine mammary gland. Cancer Res. 53: 3880-3886, 1993.
3. Bayreuther, K., Rodemann, H.P., Hommel, R., Dittmann, K., Albiez, M. and Francz, P.I. Human skin fibroblasts in vitro differentiate along a terminal cell lineage. Proc. Natl. Acad. Sci. USA 85: 5112-5116, 1988.
4. Bayreuther, K., Rodemann, H.P., Francz, P.I. and Maier, K. Differentiation of fibroblast stem cells. J. Cell Sci. 10 (Suppl.): 115-130, 1988.
5. Bayreuther, K., Francz, P.I. and Rodemann, H.P. Fibroblasts in normal and pathological terminal differentiation, aging, apoptosis and transformation. Arch. Gerontol. Geriatr. 3 (Suppl.): 47-74, 1992.
6. Begg, A.C. Prediction of repopulation rates and radiosensitivity in human tumours. Int. J. Radiat. Biol. 65: 103-108, 1994.
7. Bentzen, S.M., Juul Christensen, J., Overgaard, J. and Overgaard, M. Some methodological problems in estimating radiobiological parameters from clinical data. Acta Oncol. 27: 105-116, 1988.
8. Bentzen, S.M., Thames, H.D. and Overgaard, M. Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study. Radiother. Oncol. 15: 267-274, 1989.
9. Bentzen, S.M., Overgaard, J. and Overgaard, M. Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity. Eur. J. Cancer 29A: 1373-1376, 1993.
10. Bentzen, S.M., Skoczylas, J.Z., Overgaard, M. and Overgaard, J. Radiotherapy-related lung fibrosis enhanced by tamoxifen. J. Natl. Cancer Inst. 88: 918-922, 1996.
11. Brock, W.A., Tucker, S.L., Geara, F.B., et al. Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 32: 1371-1379, 1995.
12. Burnet, N.G., Nyman, J., Turesson, I., Wurm, R., Yarnold, J.R. and Peacock, J.H. Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity. Lancet 339: 1570-1571, 1992.
13. Burnet, N.G., Wurm, R. and Peacock, J.H. Low dose-rate fibroblast radiosensitivity and the prediction of patient response to radiotherapy. Int. J. Radiat. Biol. 70: 289-300, 1996.
14. Butta, A., MacLennan, K., Flanders, K.C., et al. Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res. 52: 4261-4264, 1992.
15. Canney, P.A. and Dean, S. Transforming growth factor β. A promotor of late connective tissue injury following radiotherapy? Br. J. Radiol. 63: 620-623, 1990.
16. Colletta, A.A., Wakefield, L.M., Howell, F.V., et al. Anti-estrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. Br. J. Cancer 62: 405-409, 1990.
17. Cornforth, M.N. and Bedford, J.S. A quantitative comparison of potentially lethal damage repair and the rejoining of interphase chromosome breaks in low passage normal human fibroblasts. Radiat. Res. 111: 385-405, 1987.
18. Dittmann, K., Löffler, H., Bamberg, M. and Rodemann, H.P. Bowman-Birk proteinase inhibitor (BBI) modulates radiosensitivity and radiation-induced differentiation of human fibroblasts in culture. Radiother. Oncol. 34: 137-143, 1995.
19. Fairbairn, D.W., Olive, P.L. and O'Neill, K.L. The comet assay: a comprehensive review. Mutat. Res. 339: 37-59, 1995.
20. Finkelstein, J.N., Johnston, C.J., Baggs, R. and Rubin, P. Early alterations in extracellular matrix and transforming growth factor gene expression in mouse lung indicative of late radiation fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 28: 621-631, 1994.
21. Geara, F.B., Peters, L.J., Ang, K.K., Wike, J.L. and Brock, W.A. Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int. J. Radiat. Oncol. Biol. Phys. 27: 1173-1179, 1993.
22. Hayflick, L. Recent advances in the cell biology of aging. Mech. Ageing Dev. 14: 59-79, 1980.
23. Johansen, J. Relationship between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of late normal tissue reactions after radiotherapy. Ph.D. Thesis, University of Aarhus, 1995.
24. Johansen, J., Bentzen, S.M., Overgaard, J. and Overgaard, M. Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy. Int. J. Radiat. Biol. 66: 407-412, 1994.
25. Johansen, J., Bentzen, S.M., Overgaard, J. and Overgaard, M. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia and skin erythema after radiotherapy. Radiother. Oncol. 40: 101-109, 1996.
26. Klaude, M., Erikson, S., Nygren, J. and Ahnström, G. The comet assay: mechanisms and technical considerations. Mutat. Res. 363: 89-96, 1996.
27. Langberg, C.W., Hauer-Jensen, M., Sung, C.-C. and Kane, C.J.M. Expression of fibrogenic cytokines in rat small intestine after fractionated irradiation. Radiother. Oncol. 32: 29-36, 1994.
28. Lara, P.C., Russell, N.S., Smolders, I.J.H., Bartelink, H., Begg, A.C. and Coco-Martin, J.M. Radiation-induced differentiation of human skin fibroblasts: relationship with cell survival and collagen production. Int. J. Radiat. Biol. 70: 683-692, 1996.
29. Martin, M., Lefaix, J.-L., Pinton, P., Crechet, F. and Daburon, F. Temporal modulation of TGF-β1 and β-actin gene expression in pig skin and muscular fibrosis after ionizing radiation. Radiat. Res. 134: 63-70, 1993.
30. Müller, W.U., Nusse, M., Miller, B.M., Slavotinek, A., Viaggi, S. and Streffer, C. Micronuclei: a biological indicator of radiation damage. Mutat. Res. 366: 163-169, 1996.
31. Overgaard, M., Bentzen, S.M., Juul Christensen, J. and Hjøllund Madsen, E. The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation. Radiother. Oncol. 9: 1-12, 1987.
32. Ramsay, J. and Birrell, G. Normal tissue radiosensitivity in breast cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 31: 339-344, 1995.
33. Rodemann, H.P. Differential degradation of intracellular proteins in human skin fibroblasts of mitotic and mitomycin-C (MMC)-induced postmitotic differentiation states in vitro. Differentiation 42: 37-43, 1989.
34. Rodemann, H.P. and Bamberg, M. Cellular basis of radiation-induced fibrosis. Radiother. Oncol. 35: 83-90, 1995.
35. Rodemann, H.P., Bayreuther, K., Francz, P.I., Dittmann, K. and Albiez, M. Selective enrichment and biochemical characterization of seven human skin fibroblasts cell types in vitro. Exp. Cell Res. 180: 84-93, 1989.
36. Rodemann, H.P., Peterson, H.-P., Schwenke, K. and von Wangenheim, K.-H. Terminal differentiation of human fibroblasts is induced by radiation. Scanning Microscopy 5: 1135-1143, 1991.
37. Rodemann, H.P., Binder, A., Burger, A., Güven, N., Löffler, H. and Bamberg, M. The underlying cellular mechanism of fibrosis. Kidney Int. 49 (Suppl. 54): S32-S36, 1996.
38. Rubin, P., Finkelstein, J. and Shapiro, D. Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: interrelationship between the alveolar macrophage and the septal fibroblasts. Int. J. Radiat. Oncol. Biol. Phys. 24: 93-101, 1992.
39. Russell, N.S., Arlett, C.F., Bartelink, H. and Begg, A.C. Use of fluorescence in situ hybridization to determine the relationship between chromosome aberrations and cell survival in eight human fibroblast strains. Int. J. Radiat. Biol. 68: 185-196, 1995.
40. Sasai, K., Evans, J.W., Kovacs, M.S. and Brown, J.M. Prediction of human cell radiosensitivity: comparison of clonogenic assay with chromosome aberrations scored using premature chromosome condensation with fluorescence in situ hybridization. Int. J. Radiat. Oncol. Biol. Phys. 30: 1127-1132, 1994.
41. 60Co γ-irradiation in vitro. Int. J. Radiat. Biol. 70: 521-527, 1996.
42. Tucker, S.L., Turesson, I. and Thames, H.D. Evidence for individual differences in the radiosensitivity of human skin. Eur. J. Cancer 28A: 1783-1791, 1992.
43. Varga, J., Rosenbloom, J. and Jimenez, S. TGFβ causes a persistent increase in the steady-state amounts of type I and type III collagen and fibronectin in normal dermal fibroblasts. Biochem. J. 247: 597-604, 1987.
44. West, C.M. Predictive assays in radiation therapy. Adv. Radiat. Biol. 18: 149-180, 1994.
45. Wurm, R., Burnet, N.G., Duggal, N., Yarnold, J.R. and Peacock, J.H. Cellular radiosensitivity and DNA damage in primary human fibroblasts. Int. J. Radiat. Oncol. Biol. Phys. 30: 625-633, 1994.